Lung Neoplasms

Lung Cancer

Lung Adenocarcinoma

CT surveillance, Lung biopsy, Lung resection

CT scans

Singhealth Institutions

Lung Nodule Prospective Database

Devanand Anantham

Head of Lung Centre

Singapore General Hospital

Patients who undergo primary surgery will have their first study imaging surveillance at 3 months (+/- 30 days) post-surgery. CT surveillance will continue at 6,9,12,18,24 months.
During years 3-5, or long term follow up, surveillance with history and physical examination will occur every 6 months (+/- 30 days).
The last protocol-specified imaging will occur at 24 months; during long term follow-up imaging will be conducted per the judgment of the treating physicians, as indicated by the history and physical examination findings.

Patients who undergo primary radiotherapy will have their first study imaging surveillance at 6 months (+/- 30 days) post radiotherapy. The Positron Emission Tomography - Computed Tomography (PET/CT)surveillance will continue at 9,12,18,24 months.
During years 3-5, or long term follow up, surveillance with history and physical examination will occur every 6 months (+/- 30 days).
The last protocol-specified imaging will occur at 24 months; during long term follow-up imaging will be conducted per the judgment of the treating physicians, as indicated by the history and physical examination findings.

Carcinoma, Squamous Cell of Head and Neck

PET/CT

Patients who undergo primary surgery will have their first study imaging surveillance at 3 months (+/- 30 days) post-surgery. CT surveillance will continue at 6,9,12,18,24 months.
During years 3-5, or long term follow up, surveillance with history and physical examination will occur every 6 months (+/- 30 days).
The last protocol-specified imaging will occur at 24 months; during long term follow-up imaging will be conducted per the judgment of the treating physicians, as indicated by the history and physical examination findings

Computed Tomography (CT)

University of Pittsburgh Cancer Center

Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer

Efficacy of Monitoring Strategies Following Definitive Therapy for Locally Advanced Head and Neck Cancer: A Randomized, Phase III Trial of PET/CT vs. CT Surveillance

All patients will be followed for disease recurrence for at least 3 years after completing primary treatment. The date of documented disease recurrence will be noted and the elapsed time from completion of definitive therapy (surgery or last day of radiotherapy) to recurrence will serve as the co-primary endpoint. A comparison of time to recurrence between the two arms will be conducted only with patients having a documented recurrence. The outcome will be measured using tumor measurements at each follow up scan and documents using RECIST 1.1.

lymphadenopathy/نيكوتين

Lung Nodule Prospective Database

Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم